Gofen & Glossberg Has Boosted By $1.50 Million Its Amazon.Com (AMZN) Holding; Nabriva Therapeutics Plc – Ordinary Shares (NBRV) Shorts Raised By 6.71%

April 22, 2018 - By Ellis Scott

Amazon.com, Inc. (NASDAQ:AMZN) Logo

Gofen & Glossberg Llc increased Amazon.Com (AMZN) stake by 9.1% reported in 2017Q4 SEC filing. Gofen & Glossberg Llc acquired 1,280 shares as Amazon.Com (AMZN)’s stock rose 28.13%. The Gofen & Glossberg Llc holds 15,344 shares with $17.94 million value, up from 14,064 last quarter. Amazon.Com now has $739.47B valuation. The stock decreased 1.89% or $29.42 during the last trading session, reaching $1527.49. About 5.28 million shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 76.78% since April 22, 2017 and is uptrending. It has outperformed by 65.23% the S&P500.

Nabriva Therapeutics Plc – Ordinary Shares (NASDAQ:NBRV) had an increase of 6.71% in short interest. NBRV’s SI was 842,800 shares in April as released by FINRA. Its up 6.71% from 789,800 shares previously. With 628,100 avg volume, 1 days are for Nabriva Therapeutics Plc – Ordinary Shares (NASDAQ:NBRV)’s short sellers to cover NBRV’s short positions. The SI to Nabriva Therapeutics Plc – Ordinary Shares’s float is 3.63%. The stock increased 3.56% or $0.18 during the last trading session, reaching $5.23. About 459,666 shares traded or 69.69% up from the average. Nabriva Therapeutics plc (NASDAQ:NBRV) has declined 53.70% since April 22, 2017 and is downtrending. It has underperformed by 65.25% the S&P500.

Among 54 analysts covering Amazon.com (NASDAQ:AMZN), 50 have Buy rating, 0 Sell and 4 Hold. Therefore 93% are positive. Amazon.com has $2000.0 highest and $105 lowest target. $1417.88’s average target is -7.18% below currents $1527.49 stock price. Amazon.com had 287 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, October 27 by UBS. As per Friday, July 29, the company rating was maintained by Suntrust Robinson. DA Davidson initiated it with “Buy” rating and $1300.0 target in Thursday, September 7 report. On Friday, February 2 the stock rating was maintained by SunTrust with “Buy”. As per Friday, October 27, the company rating was upgraded by Raymond James. M Partners maintained Amazon.com, Inc. (NASDAQ:AMZN) on Tuesday, August 2 with “Buy” rating. The stock has “Buy” rating by BMO Capital Markets on Friday, July 28. The rating was reinitiated by Piper Jaffray on Tuesday, January 3 with “Overweight”. Canaccord Genuity maintained the shares of AMZN in report on Friday, October 23 with “Hold” rating. RBC Capital Markets maintained the stock with “Buy” rating in Friday, February 2 report.

Investors sentiment increased to 1.29 in Q4 2017. Its up 0.03, from 1.26 in 2017Q3. It improved, as 69 investors sold AMZN shares while 578 reduced holdings. 168 funds opened positions while 667 raised stakes. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. Ahl Limited Liability Partnership has 912 shares. Guild Investment Mngmt Inc accumulated 0.37% or 335 shares. Roundview Capital Lc owns 0.92% invested in Amazon.com, Inc. (NASDAQ:AMZN) for 3,041 shares. Prentiss Smith Co Inc reported 200 shares. Blackhill Cap Inc holds 0.02% or 80 shares. Cohen Klingenstein Lc, New York-based fund reported 36,528 shares. Halsey Assoc Ct holds 3.36% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 16,826 shares. Ajo LP holds 6,700 shares. Signature Estate And Investment Advsr Limited Liability Co holds 0.27% or 2,297 shares. Congress Asset Management Com Ma has invested 1.02% in Amazon.com, Inc. (NASDAQ:AMZN). Nuveen Asset Mngmt Ltd holds 0.64% or 85,497 shares in its portfolio. Generation Invest Mgmt Limited Liability Partnership stated it has 1.41% in Amazon.com, Inc. (NASDAQ:AMZN). Caisse De Depot Et Placement Du Quebec reported 69,939 shares. Culbertson A N reported 0.14% stake. Fil has 0.22% invested in Amazon.com, Inc. (NASDAQ:AMZN).

Since December 7, 2017, it had 0 buys, and 13 insider sales for $45.88 million activity. 500 shares were sold by WILKE JEFFREY A, worth $788,924 on Tuesday, March 20. ALBERG TOM A sold $3.35 million worth of stock. The insider Blackburn Jeffrey M sold 12,666 shares worth $18.50M. The insider Zapolsky David sold $3.24 million. 1,985 shares valued at $2.90M were sold by Jassy Andrew R on Thursday, February 15. $3.42M worth of Amazon.com, Inc. (NASDAQ:AMZN) shares were sold by Olsavsky Brian T. Reynolds Shelley sold $795,502 worth of Amazon.com, Inc. (NASDAQ:AMZN) on Thursday, February 15.

Gofen & Glossberg Llc decreased Walgreens Boots Alliance stake by 6,397 shares to 114,670 valued at $8.33 million in 2017Q4. It also reduced Disney Walt (NYSE:DIS) stake by 12,541 shares and now owns 400,615 shares. Qualcomm (NASDAQ:QCOM) was reduced too.

Among 5 analysts covering Nabriva Therapeutics (NASDAQ:NBRV), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Nabriva Therapeutics had 8 analyst reports since October 12, 2015 according to SRatingsIntel. Wedbush maintained the stock with “Outperform” rating in Wednesday, February 1 report. The firm has “Outperform” rating by Leerink Swann given on Tuesday, October 13. The firm has “Outperform” rating given on Thursday, November 12 by RBC Capital Markets. The firm earned “Outperform” rating on Tuesday, October 13 by RBC Capital Markets. The company was reinitiated on Thursday, October 27 by Leerink Swann. The rating was initiated by Needham on Monday, October 12 with “Buy”. The rating was initiated by Wedbush on Tuesday, October 13 with “Outperform”. The rating was initiated by Gabelli with “Buy” on Wednesday, January 27.

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>